SCHEMBL15437294

SCHEMBL15437294

N#Cc1ccc2oc(-c3ccc(CCl)cc3)nc2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CETP P11597 14/20 0.56
HDAC6 Q9UBN7 1/20 0.53
PPARG P37231 1/20 0.53
HSPD1 P10809 1/20 0.50
PTPN2 P17706 1/20 0.50
PTPN1 P18031 1/20 0.50
PTPN5 P54829 1/20 0.50
HSPE1 P61604 1/20 0.50
PDE10A Q9Y233 1/20 0.49
KDM4E B2RXH2 1/20 0.48
MEN1 O00255 1/20 0.48
NPC1 O15118 1/20 0.48
ALDH1A1 P00352 1/20 0.48
TP53 P04637 1/20 0.48
MAPT P10636 1/20 0.48
HPGD P15428 1/20 0.48
NFKB1 P19838 1/20 0.48
RAB9A P51151 1/20 0.48
NFKB2 Q00653 1/20 0.48
KMT2A Q03164 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11384170 0.86 CETP (0.56) CETPHDAC6PPARGHSPD1PTPN2
SCHEMBL11642024 0.86 HDAC6 (0.56) CETPHDAC6PPARGHSPD1PTPN2
SCHEMBL1734880 0.82 NPC1 (0.69) CETPHDAC6HSPD1PTPN2PTPN1
SCHEMBL1733840 0.82 HDAC6 (0.60) CETPHDAC6HSPD1PTPN2PTPN1
SCHEMBL28868337 0.81 SMN1; SMN2 (0.60) CETPHDAC6HSPD1PTPN2PTPN1
SCHEMBL1736234 0.80 KDM4E (0.68) CETPKDM4EMEN1NPC1ALDH1A1
SCHEMBL31165942 0.80 PIK3CB (0.61) CETPHDAC6HSPD1PTPN2PTPN1
SCHEMBL11376267 0.80 HDAC6 (0.54) CETPHDAC6HSPD1PTPN2PTPN1
SCHEMBL11339102 0.79 HDAC6 (0.67) CETPHDAC6PPARGHSPD1PTPN2
SCHEMBL2997849 0.79 SMN1; SMN2 (0.74) KDM4EMEN1NPC1ALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2875003-B1 NEW 5-AMINOTETRAHYDROQUINOLINE-2-CARBOXYLIC ACIDS UND THEIR USE Bayer Pharma AG (DE) 2016-11-16 EP disclosed
US-8981104-B2 5-aminotetrahydroquinoline-2-carboxylic acids and their use BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2015-03-17 US disclosed
US-20140031391-A1 Novel 5-aminotetrahydroquinoline-2-carboxylic acids and their use BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2014-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140031391-A1 Novel 5-aminotetrahydroquinoline-2-carboxylic acids and their use TNNT2, TNNI3, FABP3 CETP 1346/4885HDAC6 2112/4885PPARG 165/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.